Clinical trial
Glucagon Resistance in Patients With MASLD and T2DM
NCT07246421
Study timeline
Study start (actual)2026-01-29Date precision: day
Registry last updated2026-02-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metabolic Associated Fatty Liver Diseaseunresolved
Type 2 Diabetes (T2DM)unresolved
Interventions
GlugagonOTHER
Sponsors & collaborators
University of Aarhuslead sponsor
Novo Nordisk A/Scollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07246421 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.